CBD and Epilepsy: When Every Seizure Avoided is a Story That Continues

Between one seizure and another, there is an agonizing wait. For those living with epilepsy, especially the kind that resists conventional treatments, every day without a convulsion is a victory, a breath, a thread of hope that extends.

In this scenario, cannabidiol, CBD, a non-psychoactive compound of the cannabis sativa plant, emerges as a real possibility, now backed by a systematic review and meta-analysis that gathers robust data on its efficacy. 

The research, guided by rigorous criteria, shows that CBD can reduce seizures by an average of 41% in patients with drug-resistant epilepsy. A number that is not just a statistic: it is quality of life, it is relief, it is a new beginning.

A Closer Look at the Invisible

Epilepsy is not just a neurological condition; it is also a life experience. Often silent, at other times violent, it imposes limits that go far beyond the body. Even with available treatments, about 20% of people with epilepsy do not find relief with conventional medications.

This group, called “drug-resistant,” lives on the margins of predictability. And it is precisely for these people that science has been turning its eyes and hearts, testing new paths like the use of CBD, whose anticonvulsant, neuroprotective, and even antidepressant properties are beginning to show promise.

Data That Breathe: What Science Revealed

The study analyzed several controlled and randomized clinical trials, focusing on patients with resistant epilepsy. In all of them, CBD was administered in a standardized manner, and the comparison with the placebo was clear: a difference of more than 20 percentage points in seizure reduction.

In numbers, this means that those who used CBD had a 127% greater chance of responding positively to treatment. The impact was even more notable in severe syndromes like Dravet and Lennox-Gastaut, where, in some cases, patients became completely seizure-free.

Doses, Precautions, and Uniqueness

But like any potent treatment, the use of CBD requires caution. The study shows that the response to the compound is dose-dependent, meaning that higher doses generally provide better results but also increase adverse effects, such as sedation, loss of appetite, and liver changes.

This reminds us of an old and necessary truth: every body is a universe. Not everyone reacts the same way, and what works for some may not work for others. This reinforces the urgency of personalized protocols, with careful and continuous monitoring, especially in the first months of use.

The Urgency of Thinking About Tomorrow

The majority of the studies analyzed had a short duration, around 12 weeks. This means we still know little about the effects of prolonged CBD use. More research is needed – and urgently – to understand if the benefits are sustained over time and how to minimize long-term risks.

Additionally, it is necessary to break down access barriers. In Brazil, the use of CBD is still a reality for a few. High costs, the need for importation, and the lack of inclusion in official treatment guidelines are obstacles that distance patients from a basic right: the right to health.

What Needs to Change for CBD to Reach Those Who Need It?

The review makes it clear: CBD has the potential to change lives. But this promise can only be fully realized if there are structural changes. It is necessary to invest in local research, create public access policies, include CBD in the list of essential medicines, and listen to those living with epilepsy in their daily lives.

Read Also

Cannabidiol Reduces Refractory Epilepsy Seizures by Up to 41%, USP Study Shows

Cannabis sativa Shows Potential in Epilepsy Treatment: Neuroprotection and Anticonvulsant Effects

It is also urgent to identify markers that can predict who will benefit most from the treatment. This way, we can move towards a more just, precise, and humane medicine.

It is worth remembering that CBD is not a miracle cure. But it can be, for many, the chance to live days with less pain and more presence. Science gives us the numbers, but it is in the lines in between that we read what really matters: children who return to play, adults who resume their jobs, caregivers who can rest a little more peacefully.

With information from CannaReporter.